Madrigal Pharmaceuticals (MDGL) had the highest return between November 1, 2022 and December 31, 2022 by a mid-cap US stock or mid-cap US stock, returning 301.6%.
Madrigal Pharmaceuticals (MDGL) had the highest return between November 1, 2022 and December 31, 2022 by a mid-cap US stock or mid-cap US stock, returning 301.6%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.